Jim Simons's position in Cartesian Therapeutics is currently worth $458k. That's 0.00% of their equity portfolio (2471st largest holding). The first Cartesian Therapeutics trade was made in Q2 2024. Since then Jim Simons bought shares five more times and sold shares on four occasions. The investor's estimated purchase price is $590k, resulting in a loss of 22%.